Cytek Biosciences, Inc.
CTKB· Nasdaq
Released Nov 5, 2024, after the close
10-Q filed Nov 7, 2024, 38 days after period end · 0001628280-24-045834
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $51.50M | $48.00M | $40.48M | $34.38M |
| Net Income | $941.00K | -$6.46M | $1.63M | $1.42M |
| EPS Diluted |
Cytek Biosciences, Inc. · CIK 1831915 · Engraved from SEC EDGAR
| $0.01 |
| -$0.05 |
| -$0.01 |
| $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.